You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
Title |
Post-diagnostic prescriptions for low-dose aspirin and breast cancer-specific survival: a nested case-control study in a breast cancer cohort from the UK Clinical Practice Research Datalink
|
---|---|
Published in |
Breast Cancer Research, April 2014
|
DOI | 10.1186/bcr3638 |
Pubmed ID | |
Authors |
Liam J Murray, Janine A Cooper, Carmel M Hughes, Des G Powe, Chris R Cardwell |
Abstract |
Recent observational studies indicate that post-diagnostic use of aspirin in breast cancer patients may protect against cancer progression perhaps by inhibiting cyclooxygenase-2 dependent mechanisms. Evidence also supports a crucial role for interactions between tumour cells and circulating platelets in cancer growth and dissemination, therefore, use of low-dose aspirin may reduce the risk of death from cancer in breast cancer patients. |
X Demographics
The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
Brazil | 1 | 33% |
Unknown | 2 | 67% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 2 | 67% |
Practitioners (doctors, other healthcare professionals) | 1 | 33% |
Mendeley readers
The data shown below were compiled from readership statistics for 96 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 96 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 25 | 26% |
Researcher | 20 | 21% |
Student > Master | 10 | 10% |
Student > Bachelor | 4 | 4% |
Student > Postgraduate | 4 | 4% |
Other | 15 | 16% |
Unknown | 18 | 19% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 38 | 40% |
Agricultural and Biological Sciences | 8 | 8% |
Biochemistry, Genetics and Molecular Biology | 7 | 7% |
Pharmacology, Toxicology and Pharmaceutical Science | 6 | 6% |
Nursing and Health Professions | 5 | 5% |
Other | 8 | 8% |
Unknown | 24 | 25% |
Attention Score in Context
This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 09 April 2014.
All research outputs
#15,298,293
of 22,751,628 outputs
Outputs from Breast Cancer Research
#1,429
of 1,894 outputs
Outputs of similar age
#133,004
of 226,135 outputs
Outputs of similar age from Breast Cancer Research
#17
of 28 outputs
Altmetric has tracked 22,751,628 research outputs across all sources so far. This one is in the 22nd percentile – i.e., 22% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,894 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 11.9. This one is in the 18th percentile – i.e., 18% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 226,135 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 31st percentile – i.e., 31% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 28 others from the same source and published within six weeks on either side of this one. This one is in the 35th percentile – i.e., 35% of its contemporaries scored the same or lower than it.